Diabetes, use of metformin, and the risk of meningioma.

Diabetes, use of metformin, and the risk of meningioma.

Metformin is a commonly used oral antidiabetic agent that has been associated with decreased cancer risk. However, data regarding the association between metformin use and the risk of meningioma are unavailable.We conducted a matched case-control analysis using data from the U.K.-based Clinical Prac...

Full description

Bibliographic Details
Main Authors: Corinna Seliger, Christoph R Meier, Claudia Becker, Susan S Jick, Martin Proescholdt, Ulrich Bogdahn, Peter Hau, Michael F Leitzmann
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5510861?pdf=render

Internet

http://europepmc.org/articles/PMC5510861?pdf=render

Similar Items